Category

News
Federica Righi, Head of Innovation and Business Development at Teamit Research attended the IHI Call 9 Brokerage Event in Brussels this week. The fact that nearly 1700 participants, both online and in-person, joined the event which featured 61 pitches demonstrate the high interest and expectations for Call 9’s new bottom-up approach within the research and...
Read More
At Teamit, we are proud to announce that we are part of UMBRELLA, a groundbreaking initiative aimed at transforming stroke care across Europe. Spearheaded by the Vall d’Hebron Research Institute (VHIR) and Siemens Healthineers, UMBRELLA brings together over 20 public and private partners, including Teamit, to revolutionise stroke diagnosis, prevention, and treatment. More than 1...
Read More
We are excited to announce the launch of the European Rare Diseases Research Alliance (ERDERA), a groundbreaking initiative set to redefine the landscape of rare disease research and improve the lives of the over 30 million patients across Europe and beyond. With its kick off at the beginning of September, ERDERA represents a monumental step...
Read More
In a groundbreaking collaboration, Teamit, alongside EATRIS, Lygature and ITTM, has authored an interactive Playbook that is set to enhance data sharing in pre-competitive research projects. This new resource has been commissioned by the Innovative Health Initiative (IHI) and EFPIA to unlock the full potential of data sharing and accelerate the development of solutions through...
Read More
The International Society for Pharmacoepidemiology (ISPE) will hold their 40th Annual Meeting in Berlin, August 2024. The ISPE meeting, formerly known as the International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE) is an important milestone in the pharmacoepidemiology calendar where academics, industry professionals and experts from across the world gather to share groundbreaking results,...
Read More
The PROMISE (Preparing for RSV Immunisation and Surveillance in Europe) project recently came to a close, delivering tangible results and changing the landscape of RSV prevention and treatment forever. We look back at the journey of this successful public-private partnership in which we had the privilege to participate with our expertise in project management, consortium...
Read More
Head of Partnerships at Teamit, Gianmarco di Mauro to chair a session on Pharmacovigilance and vaccines at the upcoming ISoP Mid-Year symposium in Recinte Modernista de Sant Pau (Barcelona). On 3-4 June 2024, Barcelona will host the International Society of Pharmacovigilance (ISoP) Mid-Year Symposium focused on “The value of real-world data for ensuring patient safety”....
Read More
It’s clear that impactful scientific contributions generated collaboratively are critical to address global health threats. Whilst the challenges ahead are formidable, they also present profound opportunities to effect enduring improvements in the health and well-being of our society. Within the report, you’ll delve into the transformative projects we’ve been involved in and witness the tangible...
Read More
In the ongoing battle against the COVID-19 pandemic, scientific research continues to pave the way in our understanding of vaccine safety and efficacy. Recently, Teamit Institute (with the great support of study manager Fabio Riefolo) helped make significant strides in this field, participating in two insightful publications on the safety profile of COVID-19 vaccines.  The...
Read More
The first International Conference in Drug Repurposing (#iDR24) celebrated in Barcelona on 6-7 March has been in the limelight recently. El País, an influential newspaper in Spain and Latin America, attended the event co-organised by REMEDi4LL and talked to some of the global key opinion leaders in the field of drug repurposing. The extensive article...
Read More
1 2 3 6